What researchers published on Krónikus mieloid leukémia (CML)
8374 papers, newest first.
Showing 20 of 8374
ÁttekintésLeukemia as the price of immunity? An evolutionary cost framework.Frontiers in cell and developmental biology
ÁttekintésTreatment-Free Remission in Chronic Myeloid Leukemia: A Systematic Review of Predictors of Successful Tyrosine Kinase Inhibitor Discontinuation.Cureus
Intracranial Hemorrhage as the Initial Presentation of Chronic-Phase Chronic Myeloid Leukemia in an Adolescent.Turkish journal of haematology : official journal of Turkish Society of Haematology
Correction to 'Risk factors and reasons for switching from front-line therapy in the Italian chronic myeloid leukaemia network: A cohort study'.British journal of haematology
Szisztematikus áttekintésClinical efficacy and safety of asciminib in chronic myeloid leukemia-chronic phase (CML-CP) in real-world settings: a systematic literature review.BMC cancer
Clinical characteristics and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: A final report of CML Cooperative Study Group.Leukemia research
Correction to: Patients' and healthcare providers' views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study.The oncologist
Role and mechanism of ribosomal protein S3 in tyrosine kinase inhibitor resistance in chronic myeloid leukemia.Frontiers in oncology
Dasatinib Dose Optimization With Weekend Drug Holiday for Improved Tolerability in Chronic Myeloid Leukemia (DasaHIT): A German Chronic Myeloid Leukemia Alliance Randomized Trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Development, validation, and pilot-testing of a comprehensive patient-reported EORTC custom questionnaire for monitoring real-world tyrosine kinase toxicity in chronic myeloid leukemia.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Clonal hematopoiesis in long-term survivors after allogeneic hematopoietic cell transplantation: associations with active chronic graft-versus-host disease, donor age, and transplantation for chronic myeloid leukemia.Haematologica
Genomic and transcriptomic features associated with responses and outcomes of third-generation tyrosine kinase-inhibitor therapy in chronic myeloid leukemia.Leukemia
Is Bone Marrow Examination Still Required at Diagnosis of Typical Chronic-Phase Chronic Myeloid Leukemia? Evidence From Paired Peripheral Blood and Bone Marrow Cytogenetics.American journal of hematology
ÁttekintésPredictive factors for TKI discontinuation eligibility and treatment-free remission in chronic myeloid leukemia.International journal of hematology
Pharmacological SOS1 inhibitor BI-3406 synergizes with BCR::ABL1 TKIs reducing leukemia stem cells and overcoming imatinib resistance in CML.Cell death & disease
Differential regulation of PRSS57 by tyrosine kinase inhibitors and ATRA in myeloid leukaemia cells: an in vitro study.Journal of applied genetics
Investigation of selected MiRNA as potential biomarker in chronic myeloid leukemia patients.Medicine and pharmacy reports
Capillary dried plasma microsampling: A novel approach for therapeutic drug monitoring of tyrosine kinase inhibitors in chronic myeloid leukemia patients by UPLC-MS/MS.Journal of pharmaceutical and biomedical analysis
Correction: Target inhibition of CBP induced cell senescence in BCR-ABL- T315I mutant chronic myeloid leukemia.Frontiers in oncology
Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: long-term efficacy and endocrine analysis.Blood advances